Kanseri y'amahaha ni indwara yica cane, ikaba ihitana abantu benshi.
Ni yo ndwara ya mbere yica abantu benshi kw'isi, ikaba ihitana abantu benshi kuruta abishwe na kanseri y'ibere, iya prostate n'iyo mu muhogo.
Ibitigiri vy'abapfa bahitanywe na kanseri y'amahaha inyuma y'imyaka itanu ni ibice 15 kw'ijana gusa, kandi iyo kanseri iri mu zitera umuntu umwe kuri batatu apfa ahitanywe na yo.
Igitigiri c'abapfa bahitanywe na kanseri y'amahaha cariko kiragabanuka mu bagabo kubera ko abantu batakinywa itabi cane, ariko mu bagore hoho cariko kirongerekana.
Chen WQ, Zhang SW, Zou XN, Zhao P: [An analysis of lung cancer mortality in China, 2004 - 2005]. Zhonghua Yu Fang Yi Xue Za Zhi. 2010, 44 (5): 378-82.
New M, Keith R: Early Detection and Chemoprevention of Lung Cancer. F1000Res. 2018, 7 (): 61.
Chu YJ, Liu QY, Hou C, Yu SY: Blood selenium concentration in residents of areas in China having a high incidence of lung cancer. Biol Trace Elem Res. 1984, 6 (2): 133-7.
Yamaguchi N, Mochizuki-Kobayashi Y, Utsunomiya O: Quantitative relationship between cumulative cigarette consumption and lung cancer mortality in Japan. Int J Epidemiol. 2000, 29 (6): 963-8.
Kazerouni N, Alverson CJ, Redd SC, Mott JA, Mannino DM: Sex differences in COPD and lung cancer mortality trends--United States, 1968-1999. J Womens Health (Larchmt). , 13 (1): 17-23.
Phillips AJ: An analysis of the increase in lung cancer in Canada. Can Med Assoc J. 1966, 95 (23): 1172-4.
['Urupapuro rwemeza ko ata ruhusha:']
["Uru rubuga rw'ivy'ubuvuzi ruratangwa ku bw'inyigisho no ku bw'ukumenyesha amakuru gusa, ntirutanga impanuro mu vy'ubuvuzi canke ngo rube urwego rw'abahinga mu vy'ubuvuzi."]
["Itegeko ryo mu 1998 ryerekeye uburenganzira umuntu afise mu vyo akoresha mu guhanahana amakuru (Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) ritanga uburenganzira ku bantu bafise uburenganzira bwo guhanahana amakuru babona ko ibintu vyerekanwa kuri Internet bihonyanga uburenganzira bwabo hisunzwe amategeko ya Leta Zunze Ubumwe za Amerika ajanye n'uburenganzira umuntu afise. "]
['Mu gihe wibaza ko hari ibintu canke ibikoresho vyabonetse ku rubuga rwacu canke ku mbuga zacu bibangamiye uburenganzira bwawe, wewe (canke uwukugenzura) urashobora kuturungikira ubutumwa busaba ko ivyo bintu canke ivyo bikoresho bikurwaho canke ko bitagisubira kuboneka. ']
['Amatangazo ategerezwa kurungikwa mu nyandiko hakoreshejwe ubutumwa bwa "email" (raba ahavuga ngo "Kwitaba" kugira ngo umenye aderese ya "email").']
["Itegeko rya DMCA risaba ko umenyesha ko hari uwugomba guhonyanga uburenganzira bwawe mu gutanga amakuru akurikira: (1) idondorwa ry'igikorwa gikingiwe n'amategeko kiriko kiragirizwa guhonyanga uburenganzira bwawe; (2) idondorwa ry'ibiri mu vyo bavuga ko bihonyanga uburenganzira bwawe be n'amakuru ahagije atuma dushobora kumenya aho biri; (3) amakuru y'ukuntu twokwifatanya nawe, harimwo aderese yawe, inomero za telefone n'ikete ryawe ryo kurungikiranira ubutumwa kuri internet; (4) ivyemeza ko wemera udakeka ko ivyo bintu biri mu buryo uriko uridodombera bitahawe uburenganzira n'uwabitunganije, canke uwubiserukira, canke n'itegeko iryo ari ryo ryose; "]
["(5) urwandiko rwanditswe n'uwatanze iyo notifica-tion, rwemeza ko amakuru ari muri iyo notifica-tion ari ay'ukuri kandi ko afise ububasha bwo gukurikirana ivy'uwo muntu avuga ko yahonyanze uburenganzira bwiwe; "]
['Turakwinginze uturungikire ubutumwa kuri email ufise ikibazo / iciyumviro.']
How deadly is lung cancer?
Lung cancer is a very deadly disease, with a high mortality rate.
It is the leading cause of cancer deaths worldwide, accounting for more deaths than breast, prostate, and colorectal cancers combined.
The five-year survival rate for lung cancer is only 15%, and it is responsible for one in every three cancer deaths.
The mortality rate for lung cancer has been decreasing in men due to a decrease in smoking prevalence, but it has been increasing in women.
Despite the drop in smoking rates, lung cancer remains a significant public health epidemic, and smoking cessation alone will not cure it.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
